Migraine With or Without Aura
21
1
2
18
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Published Results
11 trials with published results (52%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 21 trials
100.0%
+13.5% vs benchmark
52%
11 trials in Phase 3/4
61%
11 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (21)
New Methods for Evaluating Preventive Migraine Treatment
A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea
Cooling to Alleviate Migraine #3
Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: A Single Arm Study
Evaluation of a Wearable Device for Acute Treatment of Migraines
The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
An Acute Migraine Factorial Study
Safety and Efficacy in Adult Subjects With Acute Migraines
Trial in Adult Subjects With Acute Migraines
Open Label Safety Study in Acute Treatment of Migraine
Safety and Efficacy Study in Adult Subjects With Acute Migraines
Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine
Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo
Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study
Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine
Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan
Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine
An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine
Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine
Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine